Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Q1 2024 Earnings Call Transcript
…
50,275€
0,45%
Echtzeit-Aktienkurs Recordati - Industria Chimica e Farmaceutica S.p.A.
Bid:
Ask:
Nachrichten zur Recordati - Industria Chimica e Farmaceutica S.p.A. Aktie
Updated recommendation by the nomination committee of Navamedic ASA
Following Navamedic ASAs acquisition of Sensidose AB, the nomination committee recommends that Åsa Kornfeld, previous Board member in Sensidose AB,…
XFRA : DIVIDEND/INTEREST INFORMATION - 22.05.2023 - IT0003828271
Das Instrument RER1 IT0003828271 RECORDATI SPA EO -,125 EQUITY wird ex Dividende/Zinsen gehandelt am 22.05.2023
The instrument RER1…
Recordati ups guidance on strong growth in specialty, primary care markets
...(Reuters) - Italian drug maker Recordati hiked its 2023 guidance......…
Recordati GAAP EPS of €0.59, revenue of €551.4M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Camurus appoints Alberto Pedroncelli as Chief Medical Officer
Camurus appoints Alberto Pedroncelli as Chief Medical Officer
Lund, Sweden — 4 April 2023 — Camurus AB (NASDAQ STO: CAMX) today…
ARS Pharmaceuticals Reacquires European Marketing Rights to neffy® (ARS-1) for the Treatment of Type I Allergic Reactions Including Anaphylaxis
SAN DIEGO, Feb. 22, 2023 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to…
UPDATE 1-Recordati shares fall after core profit margin forecasts disappoint
...(Adds CFO quotes, background)
MILAN, Feb 21 (Reuters) - Shares... Reuters
that the company had been prudent in its outlook, choosing......…
Recordati reports FY results; initiates FY23 and FY25 guidance
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…